Patents Licensed From Third Parties. Each Party’s rights under Sections 6.2 and 6.4 with respect to any Licensed Patent that is licensed by Sangamo from a Third Party shall be subject to the rights retained by such Third Party. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Appears in 2 contracts
Samples: Research Collaboration and License Agreement (Sangamo Therapeutics, Inc), Research Collaboration and License Agreement (Sangamo Therapeutics, Inc)
Patents Licensed From Third Parties. Each Party’s rights under Sections 6.2 10.2, 10.3 and 6.4 10.4 with respect to any Licensed Patent that is licensed by Sangamo from a Third Party shall be subject to the rights retained by such Third Party. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission Party pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amendedapplicable Upstream License.
Appears in 1 contract
Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc)
Patents Licensed From Third Parties. Each Party’s rights under Sections 6.2 and 6.4 this Article 10 with respect to the prosecution and enforcement of any Licensed Sangamo Patent that is licensed by Sangamo from a Third Party shall be subject to the rights retained by such Third PartyParty to prosecute and enforce such Patent Rights. [ * [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Appears in 1 contract
Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc)
Patents Licensed From Third Parties. Each Party’s rights under Sections 6.2 10.2, 10.3 and 6.4 10.4 with respect to any Licensed Patent that is licensed by Sangamo from a Third Party shall be subject to the rights retained by such Third Party. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
Appears in 1 contract
Samples: Collaboration and License Agreement (Sangamo Therapeutics, Inc)
Patents Licensed From Third Parties. Each Party’s rights under Sections 6.2 and 6.4 this Article 13 with respect to the prosecution and enforcement of any Licensed Five Prime Patent that is licensed by Sangamo Five Prime from a Third Party shall be subject to the rights retained by of such Third PartyParty to prosecute and enforce such Patent. [ * [***] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.. CONFIDENTIAL EXECUTION
Appears in 1 contract
Samples: License and Collaboration Agreement (Five Prime Therapeutics Inc)
